Esperion Therapeutics Inc
(NASDAQ:ESPR)
$1.59
0.09[6.00%]
Last update: 5:06PM (Delayed 15-Minutes)
Get Real Time Here
$1.59
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open1.510Close1.580
Vol / Avg.2.159M / 3.844MMkt Cap180.811M
Day Range1.500 - 1.60052 Wk Range0.700 - 8.850

Esperion Therapeutics Stock (NASDAQ:ESPR), Quotes and News Summary

Esperion Therapeutics Stock (NASDAQ: ESPR) stock price, news, charts, stock research, profile.

Open1.510Close1.580
Vol / Avg.2.159M / 3.844MMkt Cap180.811M
Day Range1.500 - 1.60052 Wk Range0.700 - 8.850
Vandana Singh - Aug 28, 2023, 2:10PM
Lisa Levin - Jun 15, 2023, 8:10AM
Lisa Levin - May 11, 2023, 9:25AM
Lisa Levin - Apr 26, 2023, 7:45AM
Lisa Levin - Apr 6, 2023, 8:05AM
Lisa Levin - Mar 29, 2023, 7:28AM
Chris Katje - Mar 18, 2023, 4:36PM
Lisa Levin - Mar 16, 2023, 2:58PM
Lisa Levin - Mar 16, 2023, 1:56PM
Lisa Levin - Mar 16, 2023, 12:38PM
Globe Newswire - Nov 13, 2023, 10:30AM
Globe Newswire - Nov 11, 2023, 11:00AM
Globe Newswire - Nov 9, 2023, 4:30PM
Globe Newswire - Nov 7, 2023, 6:00AM
Globe Newswire - Oct 31, 2023, 8:00AM
Globe Newswire - Oct 24, 2023, 8:00AM
PRNewswire - Sep 26, 2023, 9:31AM
Globe Newswire - Sep 12, 2023, 10:15AM
Globe Newswire - Aug 28, 2023, 8:00AM
Globe Newswire - Aug 26, 2023, 11:00AM
Full archive of press releases available on Benzinga Pro
TipRanks - Nov 13, 2023, 6:30AM
Seeking Alpha - Nov 12, 2023, 10:45PM
TipRanks - Nov 8, 2023, 12:58AM
TipRanks - Nov 7, 2023, 2:40PM
Seeking Alpha - Nov 7, 2023, 1:30PM
TipRanks - Nov 7, 2023, 12:40PM
Seeking Alpha - Nov 7, 2023, 10:51AM
TipRanks - Nov 7, 2023, 10:35AM
Seeking Alpha - Nov 7, 2023, 6:03AM
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-0.430-0.370 0.0600
REV29.580M33.969M4.389M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-11-20JP MorganJessica FyeReinstatesNeutral---
2023-11-13HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-22.00
2023-11-07NeedhamSerge BelangerMaintainsBuyBuyLowers9.008.00
2023-10-02NeedhamSerge BelangerReiteratesBuyBuyMaintains-9.00

Related Companies

TickerCompanyChg %Mkt Cap
ESPREsperion Therapeutics6%180.8M
AVIRAtea Pharmaceuticals-1.34%245.3M
ZVRAZevra Therapeutics3.84%201.4M
XERSXeris Biopharma Holdings1.04%268M
LBPHLongboard Pharmaceuticals0%113.3M
Q

How do I buy Esperion Therapeutics (ESPR) stock?

A

You can purchase shares of Esperion Therapeutics (NASDAQ: ESPR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Esperion Therapeutics's (ESPR) competitors?

A

Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Longboard Pharmaceuticals (NASDAQ:LBPH) and Ocular Therapeutix (NASDAQ:OCUL).

Q

What is the target price for Esperion Therapeutics (ESPR) stock?

A

The latest price target for Esperion Therapeutics (NASDAQ: ESPR) was reported by JP Morgan on Monday, November 20, 2023. The analyst firm set a price target for 0.00 expecting ESPR to fall to within 12 months (a possible -100.00% downside). 24 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Esperion Therapeutics (ESPR)?

A

The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $1.59 last updated December 7, 2023 at 10:06 PM UTC.

Q

Does Esperion Therapeutics (ESPR) pay a dividend?

A

There is no dividend information for Esperion Therapeutics.

Q

When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?

A

Esperion Therapeutics’s Q4 earnings are confirmed for Tuesday, February 20, 2024.

Q

Is Esperion Therapeutics (ESPR) going to split?

A

There is no upcoming split for Esperion Therapeutics.

Q

What sector and industry does Esperion Therapeutics (ESPR) operate in?

A

Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.